September 2, 2025- InspiroGene™ by McKesson, a dedicated business focused on supporting the commercialization of cell and gene therapies (CGTs), launched InspiroCare™, a purpose-built patient hub designed to simplify the complex journey of cell and gene therapies. Leveraging the proven expertise of Biologics by McKesson, InspiroCare brings together decades of patient support know-how with a deep understanding of the unique CGT patient journey to help ensure patients, caregivers and providers get the support they need. The digitally enabled platform connects biopharma sponsors, providers, payers, and commercialization partners through a unified system that supports the entire patient-product journey.
“InspiroCare was created to provide personalized, compassionate support for cell and gene therapy patients, who often must navigate long, complex, and emotionally taxing paths to treatment,” said Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson. “By tailoring services to the unique CGT journey and integrating seamlessly into the workflow, InspiroCare helps ease the burden for patients and caregivers while expanding access to these life-changing therapies.”
InspiroCare delivers personalized services that empower patients, caregivers, and providers. Key features include:
● Individualized case management: Each patient is matched with a dedicated case manager who understands the unique challenges of CGTs and provides personalized, high-touch support to guide them through every step of the complex patient journey.
● Adaptable to specific needs: Biopharma sponsors can select only the services they need and scale them up or down to align with their business goals or unique patient needs.
● Integrated by design: InspiroCare is seamlessly integrated into the entire InspiroGene CGT workflow, helping to maximize efficiencies and creating a unified, end-to-end experience that simplifies coordination.
● Data transparency: InspiroCare uses the latest advanced technology to ensure full visibility into the CGT workflow.
● 24/7 access: Our extensively trained InspiroCare clinical team is available around the clock to address patient concerns and provide support throughout the patient journey.
“Biologics by McKesson, a leader in specialty pharmacy and access services for oncology, rare, and cell and gene therapies, is transforming how care is delivered—through precision, speed, and compassion,” said Ela Lourido, Vice President and General Manager, Biologics by McKesson. “By uniting the deep expertise of InspiroGene and Biologics, we’re building on a foundation of trust to deliver a seamless, end-to-end solution that accelerates access to advanced therapies. Together, we empower patients, caregivers, and providers with the support they deserve—because transforming care isn’t just our mission, it’s our promise.”